Report cover image

North America and Europe Women's Health Market - Industry Trends and Forecast to 2031

Publisher Data Bridge Market Research
Published Feb 01, 2024
Length 295 Pages
SKU # DAABD18636684

Description

North America and Europe Women's Health Market - Industry Trends and Forecast to 2031


Europe women’s health market is expected to reach USD 5,384.03 million by 2031, from USD 3,280.54 million in 2023 growing at the CAGR of 6.7% in the forecast period of 2024 to 2031.

North America women’s health market is expected to reach USD 11,108.64 million by 2031 from USD 5,841.61 million in 2023, growing at a CAGR of 9.3% in the forecast period of 2024 to 2031.

Market Segmentation

North America and Europe Women's Health Market, By Treatment (Drugs and Devices), Indication (Cancer, Reproductive Health, Urological Disorders, Hypothyroidism, Post-Menopausal Syndrome, and Others), Delivery Mode (Prescription and Over The Counter), Drug Type (Branded and Generic), Care Type (General Healthcare & Wellness, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare, and Others), End User (Hospitals and Clinics, Gynecology Centers, Homecare Settings, Homecare Setting, Research Institutes, and Others), Distribution Channel (Direct Tenders, Retail Sales, Online Sales, and Others), Country (U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Russia, Switzerland, Turkey, Belgium, Netherlands, Hungary, and Rest of Europe) - Industry Trends and Forecast to 2031

Overview of Europe Women’s Health Market Dynamics

Driver
• Rising rates of chronic debilitating conditions among women

Restrain
• Adverse effects associated with certain products

Opportunity
• Growing awareness and acceptance of fertility treatments

Market Players

Some of the major players operating in the North America and Europe women’s health market are:
• Pfizer Inc.
• Lilly
• Novartis AG
• AbbVie Inc.
• GSK plc.
• Abbott
• Noven Pharmaceuticals, Inc.
• Lupin
• Vertical Pharmaceuticals, LLC
• Veru Inc.

Table of Contents

295 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America And Europe Women’s Health Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Market Application Coverage Grid
2.8 Product Lifeline Curve
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’s Five Forces
4.3 Industry Insights
4.3.1 Drug Treatment Rate In Matured Markets
4.3.2 Demographic Trends: Impacts On All Incidence Rates
4.3.3 Patient Flow Diagrams
4.3.4 Key Pricing Strategies
4.3.5 Key Enrollment Strategies
4.4 Pipeline Analysis
4.5 Patent Data Analysis
5 Market Overview
5.1 Drivers
5.1.1 Rising Rates Of Chronic Debilitating Conditions Among Women
5.1.2 Innovative Technologies Being Developed As An Aftermath Of R&D Activities
5.1.3 Government Initiatives To Improve Overall Health And Wellbeing
5.1.4 Changing Lifestyles And Environmental Factors Impacting Health
5.2 Restraints
5.2.1 Adverse Effects Associated With Certain Products
5.2.2 Strict Regulations Imposed By The Regulatory Agencies
5.3 Opportunities
5.3.1 Increasing Recognition For Mental Health
5.3.2 Growing Awareness And Acceptance Of Fertility Treatments
5.3.3 Growing Incidences Of Sexually Transmitted Diseases
5.4 Challenges
5.4.1 Environmental Exposure Impacting Reproductive Health
5.4.2 High Maternal Mortality And Morbidity
6 North America And Europe Women’s Health Market, By Treatment
6.1 Overview
6.2 Drugs
6.3 Device
7 North America And Europe Women’s Health Market, By Indication
7.1 Overview
7.2 Cancer
7.3 Reproductive Health
7.4 Urological Disorders
7.5 Hypothyroidism
7.6 Post-menopausal Syndrome
7.7 Others
8 North America And Europe Women’s Health Market, By Care Type
8.1 Overview
8.2 General Healthcare & Wellness
8.3 Pregnancy & Nursing Care
8.4 Pelvic & Uterine Healthcare
8.5 Others
9 North America And Europe Women’s Health Market, By Drug Type
9.1 Overview
9.2 Branded
9.3 Generic 130 
10 North America And Europe Women’s Health Market, By Delivery Mode
10.1 Overview
10.2 Prescription
10.3 Over The Counter
11 North America And Europe Women’s Health Market, By End User
11.1 Overview
11.2 Hospitals And Clinics
11.3 Gynecology Centers
11.4 Homecare Setting
11.5 Research Institutes
11.6 Others
12 North America And Europe Women’s Health Market, By Distribution Channel
12.1 Overview
12.2 Direct Tenders
12.3 Retail Sales
12.4 Online Sales
12.5 Others
13 North America And Europe Women's Health Market, By Region
13.1 North America
13.1.1 U.S.
13.1.2 Canada
13.1.3 Mexico
13.2 Europe
13.2.1 Germany
13.2.2 France
13.2.3 U.K.
13.2.4 Italy
13.2.5 Russia
13.2.6 Spain
13.2.7 Turkey
13.2.8 Netherlands
13.2.9 Switzerland
13.2.10 Belgium
13.2.11 Rest Of Europe 269 
14 North America And Europe Women Health Market: Company Landscape
14.1 Company Share Analysis: North America
14.2 Company Share Analysis: Europe
15 Swot Analysis
16 Company Profile
16.1 Abbott
16.1.1 Company Snapshot
16.1.2 Revenue Analysis
16.1.3 Product Portfolio
16.1.4 Recent Development
16.2 Abbvie Inc.
16.2.1 Company Snapshot
16.2.2 Revenue Analysis
16.2.3 Product Portfolio
16.2.4 Recent Development
16.3 Gsk Plc.
16.3.1 Company Snapshot
16.3.2 Revenue Analysis
16.3.3 Product Portfolio
16.3.4 Recent Development
16.4 Lilly
16.4.1 Company Snapshot
16.4.2 Revenue Analysis
16.4.3 Product Portfolio
16.4.4 Recent Development
16.5 Lupin
16.5.1 Company Snapshot
16.5.2 Revenue Analysis
16.5.3 Product Portfolio
16.5.4 Recent Development
16.6 Novartis Ag
16.6.1 Company Snapshot
16.6.2 Revenue Analysis
16.6.3 Product Portfolio
16.6.4 Recent Development 284 
16.7 Noven Pharmaceuticals, Inc.
16.7.1 Company Snapshot
16.7.2 Product Portfolio
16.7.3 Recent Development
16.8 Pfizer Inc.
16.8.1 Company Snapshot
16.8.2 Revenue Analysis
16.8.3 Product Portfolio
16.8.4 Recent Development
16.9 Vertical Pharmaceuticals, Llc
16.9.1 Company Snapshot
16.9.2 Product Portfolio
16.9.3 Recent Development
16.10 Veru Inc.
16.10.1 Company Snapshot
16.10.2 Revenue Analysis
16.10.3 Product Portfolio
16.10.4 Recent Development
17 Questionnaire
18 Related Reports
List Of Tables
Table 1 North America And Europe Women's Health Market, Devices
Table 2 North America And Europe Women's Health Market, Drugs
Table 3 Patent Data (1/4)
Table 4 Patent Data (2/4)
Table 5 Patent Data (3/4)
Table 6 Patent Data (4/4)
Table 7 North America Women’s Health Market, By Treatment, 2022-2031 (Usd Million)
Table 8 Europe Women’s Health Market, By Treatment, 2022-2031 (Usd Million)
Table 9 North America Drugs In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 10 Europe Drugs In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 11 North America Hormonal Treatment In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 12 Europe Hormonal Treatment In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 13 North America Estrogen In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 14 Europe Estrogen In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 15 North America Progesterone In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 16 Europe Progesterone In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 17 North America Combined Estrogens & Progesterone In Women's Health Market, By Type, 2022-2031 (Usd Million
Table 18 Europe Combined Estrogens & Progesterone In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 19 North America Gonadotropins In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 20 Europe Gonadotropins In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 21 North America Gonadotropin-releasing Hormone Analogs (Gnrh Analogs) In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 22 Europe Gonadotropin-releasing Hormone Analogs (Gnrh Analogs) In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 23 North America Leuprolide Acetate In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 24 Europe Leuprolide Acetate In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 25 North America Gonadotropin-releasing Hormone Antagonist In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 26 Europe Gonadotropin-releasing Hormone Antagonist In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 27 North America Non-hormonal Treatment In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 28 Europe Non-hormonal Treatment In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 29 North America Insulin-sensitizing Agent In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 30 Europe Insulin-sensitizing Agent In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 31 North America Aromatase Inhibitors In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 32 Europe Aromatase Inhibitors In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 33 North America Nonsteroidal Anti-inflammatory Drugs In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 34 Europe Nonsteroidal Anti-inflammatory Drugs In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 35 North America Device In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 36 Europe Device In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 37 North America Intra Uterine Device In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 38 Europe Intra Uterine Device In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 39 North America Women’s Health Market, By Indication, 2022-2031 (Usd Million)
Table 40 Europe Women’s Health Market, By Indication, 2022-2031 (Usd Million)
Table 41 North America Cancer In Women’s Health Market, By Type, 2022-2031 (Usd Million)
Table 42 Europe Cancer In Women’s Health Market, By Type, 2022-2031 (Usd Million)
Table 43 North America Reproductive Health In Women’s Health Market, By Type, 2022-2031 (Usd Million)
Table 44 Europe Reproductive Health In Women’s Health Market, By Type, 2022-2031 (Usd Million)
Table 45 North America Urological Disorders In Women’s Health Market, By Type, 2022-2031 (Usd Million)
Table 46 Europe Urological Disorders In Women’s Health Market, By Type, 2022-2031 (Usd Million)
Table 47 North America Others In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 48 Europe Others In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 49 North America Women’s Health Market, By Care Type, 2022-2031 (Usd Million)
Table 50 Europe Women’s Health Market, By Care Type, 2022-2031 (Usd Million)
Table 51 North America General Healthcare & Wellness In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 52 Europe General Healthcare & Wellness In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 53 North America Pregnancy & Nursing Care In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 54 Europe Pregnancy & Nursing Care In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 55 North America Pelvic & Uterine Healthcare In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 56 Europe Pelvic & Uterine Healthcare In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 57 North America Women's Health Market, By Drug Type, 2022-2031 (Usd Million)
Table 58 Europe Women's Health Market, By Drug Type, 2022-2031 (Usd Million)
Table 59 North America Women's Health Market, By Delivery Mode, 2022-2031 (Usd Million)
Table 60 Europe Women's Health Market, By Delivery Mode, 2022-2031 (Usd Million)
Table 61 North America Women’s Health Market, By End User, 2022-2031 (Usd Million)
Table 62 Europe Women’s Health Market, By End User, 2022-2031 (Usd Million)
Table 63 North America Women’s Health Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 64 Europe Women’s Health Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 65 North America Women's Health Market, By Country, 2022-2031 (Usd Million)
Table 66 U.S. Women's Health Market, By Treatment, 2022-2031 (Usd Million)
Table 67 U.S. Drugs In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 68 U.S. Hormonal Treatment In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 69 U.S. Estrogen In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 70 U.S. Progesterone In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 71 U.S. Combined Estrogens & Progesterone In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 72 U.S. Gonadotropins In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 73 U.S. Gonadotropin-releasing Hormone Analogs (Gnrh Analogs) In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 74 U.S. Leuprolide Acetate In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 75 U.S. Gonadotropin-releasing Hormone Antagonist In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 76 U.S. Non-hormonal Treatment In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 77 U.S. Insulin Sensitizing Agent In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 78 U.S. Aromatase Inhibitors In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 79 U.S. Nonsteroidal Anti-inflammatory Drugs In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 80 U.S. Device In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 81 U.S. Intra Uterine Device In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 82 U.S. Women's Health Market, By Indication, 2022-2031 (Usd Million)
Table 83 U.S. Cancer In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 84 U.S. Reproductive Health In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 85 U.S. Urological Disorders In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 86 U.S. Others In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 87 U.S. Women's Health Market, By Delivery Mode, 2022-2031 (Usd Million)
Table 88 U.S. Women's Health Market, By Drug Type, 2022-2031 (Usd Million)
Table 89 U.S. Women's Health Market, By Care Type, 2022-2031 (Usd Million)
Table 90 U.S. General Healthcare & Wellness In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 91 U.S. Pregnancy & Nursing Care In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 92 U.S. Pelvic & Uterine Healthcare In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 93 U.S. Women's Health Market, By End User, 2022-2031 (Usd Million)
Table 94 U.S. Women's Health Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 95 Canada Women's Health Market, By Treatment, 2022-2031 (Usd Million)
Table 96 Canada Drugs In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 97 Canada Hormonal Treatment In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 98 Canada Estrogen In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 99 Canada Progesterone In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 100 Canada Combined Estrogens & Progesterone In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 101 Canada Gonadotropins In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 102 Canada Gonadotropin-releasing Hormone Analogs (Gnrh Analogs) In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 103 Canada Leuprolide Acetate In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 104 Canada Gonadotropin-releasing Hormone Antagonist In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 105 Canada Non-hormonal Treatment In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 106 Canada Insulin Sensitizing Agent In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 107 Canada Aromatase Inhibitors In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 108 Canada Nonsteroidal Anti-inflammatory Drugs In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 109 Canada Device In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 110 Canada Intra Uterine Device In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 111 Canada Women's Health Market, By Indication, 2022-2031 (Usd Million)
Table 112 Canada Cancer In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 113 Canada Reproductive Health In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 114 Canada Urological Disorders In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 115 Canada Others In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 116 Canada Women's Health Market, By Delivery Mode, 2022-2031 (Usd Million)
Table 117 Canada Women's Health Market, By Drug Type, 2022-2031 (Usd Million)
Table 118 Canada Women's Health Market, By Care Type, 2022-2031 (Usd Million)
Table 119 Canada General Healthcare & Wellness In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 120 Canada Pregnancy & Nursing Care In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 121 Canada Pelvic & Uterine Healthcare In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 122 Canada Women's Health Market, By End User, 2022-2031 (Usd Million)
Table 123 Canada Women's Health Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 124 Mexico Women's Health Market, By Treatment, 2022-2031 (Usd Million)
Table 125 Mexico Drugs In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 126 Mexico Hormonal Treatment In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 127 Mexico Estrogen In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 128 Mexico Progesterone In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 129 Mexico Combined Estrogens & Progesterone In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 130 Mexico Gonadotropins In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 131 Mexico Gonadotropin-releasing Hormone Analogs (Gnrh Analogs) In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 132 Mexico Leuprolide Acetate In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 133 Mexico Gonadotropin-releasing Hormone Antagonist In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 134 Mexico Non-hormonal Treatment In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 135 Mexico Insulin Sensitizing Agent In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 136 Mexico Aromatase Inhibitors In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 137 Mexico Nonsteroidal Anti-inflammatory Drugs In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 138 Mexico Device In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 139 Mexico Intra Uterine Device In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 140 Mexico Women's Health Market, By Indication, 2022-2031 (Usd Million)
Table 141 Mexico Cancer In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 142 Mexico Reproductive Health In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 143 Mexico Urological Disorders In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 144 Mexico Others In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 145 Mexico Women's Health Market, By Delivery Mode, 2022-2031 (Usd Million)
Table 146 Mexico Women's Health Market, By Drug Type, 2022-2031 (Usd Million)
Table 147 Mexico Women's Health Market, By Care Type, 2022-2031 (Usd Million)
Table 148 Mexico General Healthcare & Wellness In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 149 Mexico Pregnancy & Nursing Care In Women's Health Market, By Type, 2022-2031 (Usd Million)
Table 150 Mexico Pelvic & Uterine Healthcare In Women's Health Market, By Type, 2022-2031 (Usd Million)
List Of Figures
Figure 1 North America And Europe Women’s Health Market: Segmentation
Figure 2 North America And Europe Women’s Health Market: Data Triangulation
Figure 3 North America And Europe Women’s Health Market: Droc Analysis
Figure 4 North America And Europe Women’s Health Market: Regional Vs Country Market Analysis
Figure 5 North America And Europe Women’s Health Market: Company Research Analysis
Figure 6 North America And Europe Women’s Health Market: Interview Demographics
Figure 7 North America And Europe Women’s Health Market: Market Application Coverage Grid
Figure 8 North America And Europe Women’s Health Market: Dbmr Market Position Grid
Figure 9 North America And Europe Women’s Health Market: Vendor Share Analysis
Figure 10 North America And Europe Women’s Health Market: Segmentation
Figure 11 The Rising Rates Of Chronic Debilitating Conditions Among Women Is Expected To Drive The Growth Of The North America And Europe Women’s Health Market From 2024 To 2031
Figure 12 The Treatment Segment Is Expected To Account For The Largest Share Of The North America And Europe Women’s Health Market In 2024 And 2031
Figure 13 Drivers, Restraints, Opportunities, And Challenge Of North America And Europe Women's Health Market
Figure 14 North America Women’s Health Market: By Treatment, 2023
Figure 15 North America Women’s Health Market: By Treatment, 2024-2031 (Usd Million)
Figure 16 North America Women’s Health Market: By Treatment, Cagr (2024-2031)
Figure 17 North America Women’s Health Market: By Treatment, Lifeline Curve
Figure 18 Europe Women’s Health Market: By Treatment, 2023
Figure 19 Europe Women’s Health Market: By Treatment, 2024-2031 (Usd Million)
Figure 20 Europe Women’s Health Market: By Treatment, Cagr (2024-2031)
Figure 21 Europe Women’s Health Market: By Treatment, Lifeline Curve
Figure 22 North America Women’s Health Market: By Indication, 2023
Figure 23 North America Women’s Health Market: By Indication, 2024-2031 (Usd Million)
Figure 24 North America Women’s Health Market: By Indication, Cagr (2024-2031)
Figure 25 North America Women’s Health Market: By Indication, Lifeline Curve
Figure 26 Europe Women’s Health Market: By Indication, 2023
Figure 27 Europe Women’s Health Market: By Indication, 2024-2031 (Usd Million)
Figure 28 Europe Women’s Health Market: By Indication, Cagr (2024-2031)
Figure 29 Europe Women’s Health Market: By Indication, Lifeline Curve
Figure 30 North America Women’s Health Market: By Care Type, 2023
Figure 31 North America Women’s Health Market: By Care Type, 2024-2031 (Usd Million)
Figure 32 North America Women’s Health Market: By Care Type, Cagr (2024-2031)
Figure 33 North America Women’s Health Market: By Care Type, Lifeline Curve
Figure 34 Europe Women’s Health Market: By Care Type, 2023
Figure 35 Europe Women’s Health Market: By Care Type, 2024-2031 (Usd Million)
Figure 36 Europe Women’s Health Market: By Care Type, Cagr (2024-2031)
Figure 37 Europe Women’s Health Market: By Care Type, Lifeline Curve
Figure 38 North America Women’s Health Market: By Drug Type, 2023
Figure 39 North America Women’s Health Market: By Drug Type, 2024-2031 (Usd Million)
Figure 40 North America Women’s Health Market: By Drug Type, Cagr (2024-2031)
Figure 41 North America Women’s Health Market: By Drug Type, Lifeline Curve
Figure 42 Europe Women’s Health Market: By Drug Type, 2023
Figure 43 Europe Women’s Health Market: By Drug Type, 2024-2031 (Usd Million)
Figure 44 Europe Women’s Health Market: By Drug Type, Cagr (2024-2031)
Figure 45 Europe Women’s Health Market: By Drug Type, Lifeline Curve
Figure 46 North America Women’s Health Market: By Delivery Mode, 2023
Figure 47 North America Women’s Health Market: By Delivery Mode, 2024-2031 (Usd Million)
Figure 48 North America Women’s Health Market: By Delivery Mode, Cagr (2024-2031)
Figure 49 North America Women’s Health Market: By Delivery Mode, Lifeline Curve
Figure 50 Europe Women’s Health Market: By Delivery Mode, 2023
Figure 51 Europe Women’s Health Market: By Delivery Mode, 2024-2031 (Usd Million)
Figure 52 Europe Women’s Health Market: By Delivery Mode, Cagr (2024-2031)
Figure 53 Europe Women’s Health Market: By Delivery Mode, Lifeline Curve
Figure 54 North America Women’s Health Market: By End User, 2023
Figure 55 North America Women’s Health Market: By End User, 2024-2031 (Usd Million)
Figure 56 North America Women’s Health Market: By End User, Cagr (2024-2031)
Figure 57 North America Women’s Health Market: By End User, Lifeline Curve
Figure 58 Europe Women’s Health Market: By End User, 2023

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us